Nephrocare Health Services Chart
Nephrocare Health Services Share Key Metrics
Volume
99207.00
Market Cap
5541.32 CR
LTQ@LTP
1@552.25
ATP
553.67
Var Margin
13.78 %
Circuit Range
450-675
Delivery %
64.17 %
Value
5.49 CR
ASM/GSM
No
Market Lot
1
Summary
Nephrocare Health Services Fundamentals
View MoreP/E Ratio
83.9
P/B Ratio
5.8
Div. Yield
0
Sector P/E
53.53
Sector P/B
-16.19
Sec. Div. Yield
2.27
Nephrocare Health Services Resistance and Support
Pivot 565.85
Resistance
First Resistance
574.5
Second Resistance
586.5
Third Resistance
595.15
Support
First Support
553.85
Second Support
545.2
Third Support
533.2
Nephrocare Health Services Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-10 | Quarterly Results |
Nephrocare Health Services News
Nephrocare Health Services Limited
Nephrocare Health Services Limited has designated its Chief Financial Officer, Prashant Vinodkumar Goenka, as the Chief Risk Officer (CRO) effective April 03, 2026. This adds CRO responsibilities to his existing finance, strategy, administration, secretarial, and technology roles, leveraging his 20+ years of banking experience.
Apr 03 2026 12:04:00
Nephrocare Health Services Ltd - 544647 - Announcement under Regulation 30 (LODR)-Change in Management
Nephroplus's Chief Financial Officer, Prashant Vinodkumar Goenka, has been additionally designated as the Chief Risk Officer (CRO). This role expansion is effective April 3, 2026, building on his existing responsibilities in finance, strategy, and administration.
Apr 03 2026 11:04:00
About Nephrocare Health Services
NSE : 760346
BSE : 544647
ISIN : INE428V01029
Our Company was incorporated as “Nephrocare Health Services Private Limited” a private limited company under the Companies Act 1956 at Hyderabad with a certificate of incorporation issued by the Assistant Registrar of Companies Andhra Pradesh (“RoC Andhra Pradesh”) on December 18 2009. Pursuant to resolutions dated April 11 2025 and June 2 2025 passed by our Board and Shareholders respectively our Company was converted into a public limited company and consequently the name of our Company was changed to “Nephrocare Health Services Limited” with a fresh certificate of incorporation dated June 18 2025 issued by the Registrar of Companies Central Registration Centre.Major events and milestones:2010- Launched our first standalone clinic in Banjara Hills Hyderabad India.2012- Launched our first Public Private Partnership (“PPP”) clinic in Sananth Nagar Hyderabad India2015- Launched 50th dialysis clinic and crossed 10000+ treatments per month2018- Acquired DaVita Care (India) Private Limited the Indian arm of DaVita Care Pte Ltd.2020- Launched operations in Philippines by acquiring Royal Care Dialysis Center Inc2022- Launched operations in Uzbekistan after the award of PPP tender.2024- Acquired a network of six clinics in Philippines pursuant to the acquisition of Renal Therapy Solutions Inc.2025- Acquired and a chain of seven clinics (AIZ Hemodialysis Center Inc. Bioregen Hemo Center Inc. Carmona Dialysis System Inc. Infini Care Health Systems Inc. and Kolff Dialysis Inc.)- Crossed 500+ clinic globally
Nephrocare Health Services Management
| Name | Position |
|---|---|
| Vikram Vuppala | Chairman & Managing Director |
| Vishal Vijay Gupta | Nominee Director of BVP Trust |
Nephrocare Health Services Similar Stocks
Blue Jet Healthcare Ltd.
416.85
1.55 (0.37%)
Thyrocare Technologies Ltd.
395.60
8.10 (2.09%)
Aarti Pharmalabs Ltd.
693.95
-12.75 (1.80%)
Kovai Medical Center & Hospital Ltd.
5637.80
63.10 (1.13%)
FDC Ltd.
359.00
-4.80 (1.32%)
Suven Life Sciences Ltd.
212.62
2.12 (1.01%)
Supriya Lifescience Ltd.
656.00
35.25 (5.68%)
Senores Pharmaceuticals Ltd.
882.50
-13.20 (1.47%)
Innova Captab Ltd.
710.40
-13.25 (1.83%)
SMS Pharmaceuticals Ltd.
420.25
12.15 (2.98%)
Nephrocare Health Services FAQs
